New Generations Vaccine Adjuvants

Vaccine adjuvants were first reported about 80 years ago and have been utilized to improve immune responses against non-living vaccines since then. Adjuvants are included in vaccines to improve immune responses to vaccine antigens. Viral infectious diseases represent a major portion of global public health concerns with thousands of demise annually. Adjuvants are immune potentiators administered concurrently with antigens in order to increase the vaccine effectiveness. These new-generation vaccine adjuvants massively work by activating the local innate immune system to trigger the antigen-specific immune response. The necessity for vaccine adjuvants was established after the discovery of safe, highly purified, but less immunogenic, synthetic antigens via innovation in recombinant DNA technology.

    Related Conference of New Generations Vaccine Adjuvants

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    New Generations Vaccine Adjuvants Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in